Royalty Pharma Meeting With Elan Investors on Bid

Royalty Pharma said it’s meeting with as many as 15 Elan Corp. shareholders from today to persuade them to accept its offer to buy the Irish drugmaker.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.